Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer

In advanced non-small cell lung cancer (NSCLC), patients with actionable genomic alterations may derive additional clinical benefit from targeted treatment compared to cytotoxic chemotherapy. Current guidelines recommend extensive testing with next generation sequencing (NGS) panels. We investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Shelley, Fung, Andrea S., Perdrizet, Kirstin A., Chen, Kaitlin, Li, Janice J. N., Le, Lisa W., Cabanero, Michael, Karsaneh, Ola Abu Al, Tsao, Ming S., Morganstein, Josh, Ranich, Laura, Smith, Adam C., Wei, Cuihong, Cheung, Carol, Shepherd, Frances A., Liu, Geoffrey, Bradbury, Penelope, Pal, Prodipto, Schwock, Joerg, Sacher, Adrian G., Law, Jennifer H., Stockley, Tracy L., Leighl, Natasha B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319994/
https://www.ncbi.nlm.nih.gov/pubmed/35877212
http://dx.doi.org/10.3390/curroncol29070352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319994/
https://www.ncbi.nlm.nih.gov/pubmed/35877212
http://dx.doi.org/10.3390/curroncol29070352

Ejemplares similares